DeepLook Medical

DeepLook Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $57M

Overview

DeepLook Medical is a private, commercial-stage diagnostics company leveraging artificial intelligence to revolutionize medical imaging interpretation. Its core product, DL Precise™, is an FDA-cleared software tool that provides one-click segmentation and enhanced visualization of lesions, aiming to improve diagnostic accuracy for radiologists, especially in mammography. The company has established commercial partnerships with leading medical imaging platform providers and is backed by a seasoned leadership team with expertise in medtech, AI, and radiology. DeepLook targets the significant market need for better tools in cancer detection, aiming to reduce unnecessary follow-up procedures and associated costs for the healthcare system.

Oncology

Technology Platform

AI/ML software platform (DL Precise™) for enhancing resolution and clarity in medical images. Provides one-click segmentation and vivid tumor morphology display, integrating directly into existing radiology workflows.

Funding History

2
Total raised:$57M
Series A$45M
Seed$12M

Opportunities

The massive volume of annual mammograms, coupled with a high rate of inconclusive results requiring follow-up, creates a direct and large addressable market.
Legislative trends mandating breast density notification are driving demand for better imaging tools.
The platform's applicability across multiple imaging modalities offers a clear path for significant product and market expansion beyond mammography.

Risk Factors

Intense competition in the AI radiology software space from both startups and large incumbents threatens market share.
Clinical adoption and securing favorable reimbursement are persistent challenges.
The company's embedded partnership model, while easing integration, creates dependency on the commercial success of its platform partners.

Competitive Landscape

DeepLook operates in the highly competitive AI-powered medical imaging diagnostics market. Competitors range from large, established medical imaging OEMs (e.g., GE HealthCare, Siemens Healthineers) integrating AI into their own systems, to independent software vendors like iCAD, Hologic's AI portfolio, and numerous venture-backed startups (e.g., Aidoc, Zebra Medical Vision, Qure.ai). Differentiation hinges on superior algorithm performance, seamless workflow integration, robust clinical evidence, and effective commercialization partnerships.